Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: J Allergy Clin Immunol. 2019 Dec 28;145(5):1406–1415. doi: 10.1016/j.jaci.2019.11.047

Figure 6. Expression of FOXK1 in AD and its modulating effect upon cytokine stimulation.

Figure 6

a) immunostaining for FOXK1 in normal, acute, and chronic AD lesional skin; b) RNA expression (from RT-PCR) of FOXK1, IL4R, CCL5, and IL32 upon the indicated cytokine stimulation in keratinocytes under control (NC) or FOXK1 knockdown (siFOXK1). *p<0.05; **p<0.01; ***p<0.001.